Search for: "Klaus v. Klaus" Results 81 - 100 of 146
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 May 2009, 1:37 pm
This is news of an appeal which has been lodged by Volker Mergel, Klaus Kampfenkel, Burkart Bill and Andreas Herden against the judgment of the Court of First Instance (Second Chamber) in Case T-335/07 Volker Merkel and Others v Office for Harmonisation in the Internal Market [available in French and German only. [read post]
27 Sep 2011, 2:24 pm
Unsurprisingly, perhaps, these were led by the German speakers such as Judge Klaus Grabinski. [read post]
2 May 2019, 10:48 am
  In the case of Fresenius v Baxter (Federal Circuit 2013), the issue of damages was outstanding when the PTAB invalidated the patent. [read post]
16 Jan 2013, 10:36 am by Florian Mueller
At the ViewSonic hearing in November, Nokia presented this logic for the first time.It would be a gross exaggeration to say that Nokia is now on the winning track, especially since Judge Andreas Mueller ("Müller" in German) generally appears to be very difficult to persuade of infringement contentions (other plaintiffs also struggled in his court), but today I got the impression that Nokia's functional infringement contentions have more than enough traction that the May 29 Nokia… [read post]
30 Apr 2019, 5:29 am
This focused on the three-step test of the Eli Lilly v Actavis UK Supreme Court decision and the subsequent UK cases applying that  test. [read post]
17 Nov 2009, 7:05 am
This didn't work all that well -- Diamond v. [read post]
4 Dec 2014, 7:01 am by Hanibal Goitom
Daniel Roque Vítolo, How to Deal with Foreign and “Off-shore” Companies in Argentina (2004). [read post]
31 Mar 2018, 8:56 am by Thorsten Bausch
Thorsten BauschThis is the last post of my series on the EPO’s vision and the current reality, this time dealing with the issue of EPO and “trust”, including trust-building measures such as transparency, fairness and respect. [read post]
1 Dec 2017, 6:20 am
The panel discussion was on the doctrine of equivalents following the Actavis v Lilly decision. [read post]